Paper18655183
Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis.
Lee DH and 1 other. J Cell Biochem, 2008. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. Papers, record 18655183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18655183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypoxia | Major topic |
| Hypoxia-Inducible Factor 1, alpha Subunit | Major topic |
| Protein Biosynthesis | Major topic |
| Quercetin | Major topic |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Male | |
| Vascular Endothelial Growth Factor A |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA96989 | NCI NIH HHS | United States | R01CA096989 | PubMed and NIH | NIH RePORTER |
| R01 CA096989 | NCI NIH HHS | United States | R01CA096989 | PubMed and NIH | NIH RePORTER |
| CA121395 | NCI NIH HHS | United States | R03CA121395 | PubMed and NIH | NIH RePORTER |
| R01 CA095191 | NCI NIH HHS | United States | R01CA095191 | PubMed and NIH | NIH RePORTER |
| CA95191 | NCI NIH HHS | United States | R01CA095191 | PubMed and NIH | NIH RePORTER |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42093837 | A 'three-axis synergy' immunotherapeutic strategy for malignant bone tumors based on natural bioactives and bioactive materials. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42093837 | PubMed |
| 41687517 | Tribulus terrestris L. confers protection against hypoxia induced pulmonary hypertension via regulation of HIF/ NF-κB signalling pathway. | J Ayurveda Integr Med | 2026 | https://conductscience.org/library/papers/41687517 | PubMed |
| 41614951 | Natural Phytochemicals as Inhibitors of HIF-1α in Breast Cancer: Review of Preclinical Evidence and Future Prospects. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41614951 | PubMed |
| 41596149 | Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41596149 | PubMed |
| 40124557 | Recent Update of Natural Compounds as HIF-1α Inhibitors in Colorectal Carcinoma. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40124557 | PubMed |
| 38799423 | Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment. | Front Immunol | 2024 | https://conductscience.org/library/papers/38799423 | PubMed |
| 38791387 | Electro-Metabolic Coupling of Cumulus-Oocyte Complex. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791387 | PubMed |
| 38429605 | Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38429605 | PubMed |
| 37736110 | Network analysis and molecular docking studies of quercetin as a potential treatment for prostate cancer. | In Silico Pharmacol | 2023 | https://conductscience.org/library/papers/37736110 | PubMed |
| 37637163 | Icariin activates far upstream element binding protein 1 to regulate hypoxia-inducible factor-1α and hypoxia-inducible factor-2α signaling and benefits chondrocytes. | PeerJ | 2023 | https://conductscience.org/library/papers/37637163 | PubMed |
| 37285263 | Single-cell profiling reveals a potent role of quercetin in promoting hair regeneration. | Protein Cell | 2023 | https://conductscience.org/library/papers/37285263 | PubMed |
| 36532768 | Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36532768 | PubMed |
| 35890106 | Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890106 | PubMed |
| 35774834 | The Regulation of Hypoxia Inducible Factor (HIF)1α Expression by Quercetin: an In Silico Study. | Acta Inform Med | 2022 | https://conductscience.org/library/papers/35774834 | PubMed |
| 35307904 | Quercetin potential effects against SARS-CoV-2 infection and COVID-19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α (HIF-1α). | Phytother Res | 2022 | https://conductscience.org/library/papers/35307904 | PubMed |
| 35158943 | Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158943 | PubMed |
| 33918290 | The Hallmarks of Flavonoids in Cancer. | Molecules | 2021 | https://conductscience.org/library/papers/33918290 | PubMed |
| 33401572 | Flavonoids Targeting HIF-1: Implications on Cancer Metabolism. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33401572 | PubMed |
| 33235435 | HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/33235435 | PubMed |
| 32273826 | Resveratrol protects mitochondrial quantity by activating SIRT1/PGC-1α expression during ovarian hypoxia. | Reprod Med Biol | 2020 | https://conductscience.org/library/papers/32273826 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18655183
GET https://conductscience.org/api/papers/v1/18655183/cited_by?page=2